FDA intelligence for life sciences

A clear line of sight into FDA data.

RegLine simplifies regulatory research and monitoring by unifying and standardizing public FDA datasets. Get notified of new records, track relevant changes, investigate company and product histories, and compile regulatory reports with less manual work.

A silent screen recording moves from the RegLine dashboard and its FDA source-activity chart to Sightline saved searches, then reviews an enforcement-letter analysis beside the original FDA PDF and a table of related letters.

Stay informed about the brands you follow

Without RegLine

Teams manually check separate sources for new records about brands, competitors, and therapeutic areas.

With RegLine

Monitor the companies, products, and topics you follow with saved searches and email alerts on your chosen schedule.

RegLine™ Monitor: stay informed about the brands you follow

Get to the source and context faster

Without RegLine

Investigating a regulatory or MLR question requires finding individual sources and manually assembling the results.

With RegLine

Research FDA records in one workflow with related company, product history, and original sources included.

RegLine™ Research: get to the source and context faster

Trace records across companies and products

Without RegLine

Misspellings, recorded-name variations, M&As, and rebrands can leave relevant records outside your search results.

With RegLine

Connect records across name variations and verified company relationships to research related history while preserving the original sources.

Trace records across companies and products

RegLine™ Connect: trace records across companies and products

Bring the evidence into review

Without RegLine

Organizing research for review requires manually copying records, dates, source links, and charts into a consistent format.

With RegLine

Prepare for critical decisions with reports that organize relevant FDA sources, dates, context, and charts into a source-backed starting point for your team.

RegLine™ Prepare: bring the evidence into review

A real example from RegLine

Put company and product history in perspective

Review approvals, labeling, listings, and enforcement events together to see what preceded an event and what changed afterward.

Pfizer Inc.

Explore this interactive timeline on a desktop for the best experience.

Pfizer Inc.

24 of 24 events · Jan 1998–Apr 2026

Routine activity

Label versions and listing records, grouped by quarter.

1998
2000
2002
2004
2006
2008
2010
2012
2014
2016
2018
2020
2022
2024
2026

Sample of RegLine's data for Pfizer, selected for illustrative purposes.

Sample of RegLine's data for Pfizer, selected for illustrative purposes.

RegLine export from Oct 21, 2026. Use RegLine for current data and original sources. Dates prior to Jan 1, 2004 may not reflect the original issue date.

Across the drug lifecycle

Bring relevant FDA history into each phase of your work

Use FDA records to understand the competitive landscape before launch, assess claims and risk communication, and track relevant changes throughout your product’s lifecycle.

Sightline keeps monitoring as your product and competitive priorities evolve.

FDA letters reflect specific circumstances at the time of publication. RegLine supports research and monitoring; it does not replace clinical, statistical, legal, medical, or regulatory judgment or guarantee compliance. Klick RegLine™ is independent of and not endorsed by the FDA.

Built for your work

Different responsibilities. A shared need for evidence.

For regulatory, compliance, and commercial professionals at pharma and biotech companies, and the agencies supporting them.

Regulatory & compliance

Find relevant enforcement letters when questions arise in MLR review. Assess the source, publication date, and circumstances before applying the context to a new or in-market asset.

Commercial & marketing

Stay current on FDA records relevant to your brands and competitors. Bring regulatory context into asset development and prepare for more informed review discussions.

Life sciences agencies

Monitor client and competitor brands across portfolios. Research relevant FDA records and bring source-backed context to client recommendations.

Frequently asked questions

A few things worth knowing.

Who is Klick RegLine™ for?

Regulatory and compliance professionals at biotech and pharma companies, and the agencies that serve them. Commercial, marketing, and medical affairs teams can also use it to research brands and understand regulatory context.

How does the free trial work?

All new RegLine accounts receive two weeks free. Sign up with your credit card and cancel anytime during your trial at no charge. Your selected subscription starts automatically when your trial ends.

What can I do with RegLine's Sightline feature?

Follow companies, brands, and therapeutic areas, then return to a personalized view of publications matching your watchlist.

What do the reports include?

Templated reports organize structured platform data around a brand or therapeutic area, including relevant enforcement records, dates, source links, and supporting statistics and charts.

How much time could this save me?

Use one to three hours per focused research task as a planning scenario, then replace it with your own measured baseline. At ten comparable tasks per month, that scenario represents 10–30 hours returned to research, review, and planning. To estimate ROI, multiply monthly task volume by the hours your team actually avoids and its fully loaded hourly cost, then compare that value with the current subscription price. The one-to-three-hour range is an illustrative input—not a measured customer result or guarantee. Actual savings depend on your starting process and the scope of each task, and every conclusion still requires review of the original sources and professional judgment.

Is this an FDA product?

Klick RegLine™ is an independent product of Klick Inc. It is not affiliated with or endorsed by the U.S. Food and Drug Administration.

Klick RegLine™

A clear line of sight into FDA data.

Get started